REG - OptiBiotix Health - Holding(s) in Company <Origin Href="QuoteRef">OPTIO.L</Origin>
RNS Number : 5557FOptiBiotix Health PLC28 July 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:iiOptiBiotix Health Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation:iiiSeneca Partners Limited
4. Full name of shareholder(s)
(if different from 3.):ivWCS Nominees Limited
Share Nominees Limited
5. Date of the transaction and date on
which the threshold is crossed or
reached:v27 July 2016
6. Date on which issuer notified:
7. Threshold(s) that is/are crossed or
reached: vi, vii5%
8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of
shares
if possible using
the ISIN CODESituation previous
to the triggering
transactionResulting situation after the triggering transaction
Number
of
SharesNumber
of
Voting
RightsNumber
of sharesNumber of voting
rights% of voting rights x
Direct
Direct xi
Indirect xii
Direct
Indirect
Ordinary shares of 0.02
3,908,949
3,908,949
3,858,949
3,858,949
4.95%
GB00BP0RTP38
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrumentExpiration
date xiiiExercise/
Conversion Period xivNumber of voting
rights that may be
acquired if the
instrument is
exercised/ converted.% of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrumentExercise price
Expiration date xvii
Exercise/
Conversion period xviiiNumber of voting rights instrument refers to
% of voting rights xix, xx
Nominal
Delta
Total (A+B+C)
Number of voting rights
Percentage of voting rights
3,858,949
4.95%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will ceaseto hold:
12. Date on which proxy holder will cease to holdvoting rights:
13. Additional information:
14. Contact name:
Anthony Lappin
15. Contact telephone number:
01942 271 746
This information is provided by RNSThe company news service from the London Stock ExchangeENDHOLPGUQPMUPQGWR
Recent news on OptiBiotix Health
See all newsRCS - OptiBiotix Health - Manufacturing agreement with KAG Industries
AnnouncementREG - OptiBiotix Health - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 28/03/2024
AnnouncementREG - OptiBiotix Health - Placing, Subscription and Director Dealing
AnnouncementREG - SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
Announcement